WallStSmart

Blackstone Group Inc (BX)vsHelius Medical Technologies Inc Class A (HSDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Blackstone Group Inc generates 150045% more annual revenue ($14.40B vs $9.59M). BX leads profitability with a 21.2% profit margin vs 0.0%. BX earns a higher WallStSmart Score of 61/100 (C+).

BX

Buy

61

out of 100

Grade: C+

Growth: 6.7Profit: 9.0Value: 5.0Quality: 3.5
Piotroski: 3/9Altman Z: 1.29

HSDT

Hold

37

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 6.5
Piotroski: 4/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BX4 strengths · Avg: 9.5/10
Return on EquityProfitability
36.5%10/10

Every $100 of equity generates 36 in profit

Operating MarginProfitability
38.0%10/10

Strong operational efficiency at 38.0%

Market CapQuality
$140.45B9/10

Large-cap with strong market position

Profit MarginProfitability
21.2%9/10

Keeps 21 of every $100 in revenue as profit

HSDT2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
7290.0%10/10

Revenue surging 7290.0% year-over-year

Areas to Watch

BX4 concerns · Avg: 4.0/10
PEG RatioValuation
1.964/10

Expensive relative to growth rate

P/E RatioValuation
29.5x4/10

Moderate valuation

Price/BookValuation
11.1x4/10

Trading at 11.1x book value

EPS GrowthGrowth
3.9%4/10

3.9% earnings growth

HSDT4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$74.15M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-137.4%2/10

ROE of -137.4% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BX

The strongest argument for BX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.2% and operating margin at 38.0%.

Bull Case : HSDT

The strongest argument for HSDT centers on Price/Book, Revenue Growth. Revenue growth of 7290.0% demonstrates continued momentum.

Bear Case : BX

The primary concerns for BX are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 1.69 is elevated, increasing financial risk.

Bear Case : HSDT

The primary concerns for HSDT are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

BX profiles as a mature stock while HSDT is a hypergrowth play — different risk/reward profiles.

BX carries more volatility with a beta of 1.63 — expect wider price swings.

HSDT is growing revenue faster at 7290.0% — sustainability is the question.

BX generates stronger free cash flow (958M), providing more financial flexibility.

Bottom Line

BX scores higher overall (61/100 vs 37/100), backed by strong 21.2% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Blackstone Group Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.

Helius Medical Technologies Inc Class A

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.

Want to dig deeper into these stocks?